An interventional study of Rapid weight loss (RWL) program and Gradual weight loss (GWL) program in Obesity, sponsored by The Hospital of Vestfold. Completed at 1 site in Norway. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-22.
Sponsored by The Hospital of Vestfold · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 116 studies in Obesity with a site in Norway — 3 open to participants now, 13 under way, 1 of them phase 3. Obesity · Norway.
Among the 116 studies in Obesity with a site in Norway, this one is the 16th largest by enrollment of the 103 interventional ones that give a count, is one of 7 that started in 2019, is one of 86 with no phase, and was the 84th registered.
11,564 studies on the registry are indexed under Obesity; 2,063 are open to participants now.
Browse Obesity studies →3 of the 116 studies in Obesity with a site in Norway are open now. Recruiting first, the newest first:
Haukeland University Hospital · Sites in Norway
Ages 18–65
St. Olavs Hospital · Sites in Norway
Ages 18+
Oslo University Hospital · Sites in Norway
Ages 18–70
A study can be open while its sites in Norway have not opened yet or have stopped. Only those recruiting at a site in Norway →
Of the 1,352 Obesity studies recruiting now, 382 (28%) set no upper age limit and 867 (64%) stop at 75 or younger; 169 take children under 18; 491 take healthy volunteers.
This study: 18 Years and older · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
116 studies; the count open now beside each. This study's row is marked.
First in 2004; this study’s year is marked. 7 started in 2019.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 293 is above the median of 67 across 9,043 interventional studies indexed under Obesity.
Median enrollment 64 across the 103 interventional studies, 150 across the 13 observational. Of the 90 that completed or were terminated, 6 (7%) have results posted.
This tab as a report to print or save as PDF → With an account.
14 of 116 have an industry lead sponsor. The 10 most frequent:
The Hospital of Vestfold is the lead sponsor of 16 studies on the registry; 2 are open to participants now.
The Hospital of Vestfold has 3 studies filed under Obesity — fewer than ten, so there is no comparison to draw.
6 of the studies in Obesity with a site in Norway that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07220642Phase 3Novo Nordisk A/SWeight Loss in People Living With Overweight or Obesity Following Treatment With Cagrilintide | 2027-05-11 |
| NCT06617689St. Olavs HospitalEffect of Patient Education on Drinking Behaviour and Oral Hygiene in Patients Undergoing Bariatric Surgery | 2026-12 |
| NCT07103005VID Specialized UniversityLifestyle Change: The Impact on Body Composition, Resting Metabolic Rate, Food Intake and Health-related Quality of Life | 2026-12-31 |
| NCT07113561Norwegian University of Science and TechnologyEffects of a High-protein Diet and Resistance Training on Fat-mass Loss Maintenance | 2027-01 |
| NCT07036562Norwegian University of Science and TechnologyTime-restricted Eating and High-intensity Interval Training for Metabolic Health in Adults With Overweight/Obesity | 2027-07 |
Add all 6 to your calendar (.ics) → With an account.
Among the 116 studies in Obesity with a site in Norway, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This randomized controlled trial aims to compare the 1-year effectiveness of an initial rapid weight loss (RWL) program and a gradual weight loss (GWL) program.
A total of at least 286 participants will be randomized to either a 16-week rapid weight loss (RWL) program; [an 8-week low-energy-diet (\<1000 kcal/day) - followed by an 8-week gradual increase in energy intake (4 weeks \<1300 kcal/day and 4 weeks \<1500 kcal/day)], or a 16-week gradual weight loss (GWL) program (controls); [estimated total energy expenditure minus 800-1000 kcal/day]. Thereafter, all participants (both groups) will undergo a 36-week comprehensive weight maintenance program.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Willing and able to give for participation in the study
Exclusion Criteria:
Pregnancy and breast-feeding mothers
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
16-week rapid weight loss (RWL) program \[8-week LED (\<1000 kcal/day) - followed by an 8-week gradual increase in energy intake (4 weeks \<1300 kcal/day and 4 weeks \<1500 kcal/day)\] followed by a 36-weight loss maintenance program.
Other: Rapid weight loss (RWL) program
16-week GWL-program (estimated total energy expenditure minus 800-1000 kcal/day) followed by a 36-weight loss maintenance program.
Other: Gradual weight loss (GWL) program
16-week rapid weight loss (RWL) program (8-week low energy diet (LED) followed by 8-week gradual increased energy intake) and a subsequent 36-week weight-maintenance follow-up
16-week gradual weight loss (GWL) program (moderate calorie restriction) and a subsequent 36-week weight-maintenance follow-up
Change in body weight from baseline to 12 months
Percent total body weight loss (%TBWL) at 12 months follow-up
Time frame: Baseline to 1-year
Changes in anthropometric measures
Waist and hip circumference (cm)
Time frame: 4-month and 1-year
Changes in body composition 1
Bioelectrical Impedance Analysis (BIA)
Time frame: 4-month and 1-year
Changes in body composition 2
Dual-energy X-ray Absorptiometry (DXA) in selected participants
Time frame: 4-month and 1-year
Changes in lipids
Total-cholesterol, HDL-cholesterol, LDL-cholesterol and triglycerides (mmol/l)
Time frame: 4-month and 1-year
Changes in blood pressure
Systolic and diastolic blood pressure (mm/Hg)
Time frame: 4-month and 1-year
Changes in glucose parameters
HbA1c (mmol/mol)
Time frame: 4-month and 1-year
Changes in CRP
CRP (mg/L)
Time frame: 4-month and 1-year
Changes in Health Related Quality of Life 1
Generic questionnaire: Short Form-36 Health Survey, SF36. Each item is scored on a 0 to 100 range so that the lowest and highest possible scores are 0 and 100, respectively. Scores for each of the 8 domains and summary scores for physical and mental health will be calculated
Time frame: 4-month and 1-year
Changes in Health Related Quality of Life 2
Obesity specific questionnaire: IWQOL-lite. The IWQOL-Lite is a 31-item measure of weight-related quality of life. There are five domain scores (Physical Function, Self-Esteem, Sexual Life, Public Distress and Work) and a total score. Scores for all domains and total score range from 0-100, with lower scores indicating greater impairment.
Time frame: 4-month and 1-year
Changes in Health Related Quality of Life 3
Weight-related Symptom Measure (WRSM). The validated obesity specific WRSM measures 20 symptoms commonly related to being overweight or obese, including foot problems, joint pain, sensitivity to cold, shortness of breath, etc. using two different sets of items. The first set assesses whether or not a patient is experiencing specific symptoms, and the second set rates the level of the distress of the symptoms with values from zero ("not at all") to six ("bothers a very great deal"). The first set creates an additive scale summing symptoms from 0-20, while the second forms a symptom distress scale ranging from 0-120.
Time frame: 4-month and 1-year
Changes in symptoms of depression and anxiety
Hospital Anxiety and Depression Scale (HADS). The validated generic HADS measures symptoms of anxiety and depression using 14 items scored from 0-3 It is decomposed into two domains measuring depression (HADS-D) and anxiety (HADS-A), both consisting of seven items yielding a score from 0-21.
Time frame: 4-month and 1-year
Changes in eating behavior
The Three Factor Eating Questionnaire -R 21 (TFEQ-R21) measures eating behaviour and has been validated for use in individuals with obesity and will be used in the study. It consists of 21 items comprising three domain scores; (1) uncontrolled eating; assessing the tendency to lose control over eating when feeling hungry or when exposed to external stimuli, (2) cognitive restraint; assessing the conscious restriction of food intake to control body weight or body shape, and (3) emotional eating; assessing overeating related to negative mood states. The domain scores were transformed to 0-100 scales to facilitate comparison; a higher score indicates more uncontrolled, restraint, or emotional eating.
Time frame: 4-month and 1-year
Change in weight from baseline to 4 months
Percent total body weight loss (%TBWL) at 4 months follow-up
Time frame: 4-month
Proportions of participants with a TBWL of ≥ 5%, ≥10% and ≥15% at 52-week
TBWL of ≥ 5%, ≥10% and ≥15% at 52-week follow-up
Time frame: 1-year
Plan to share: No
No publications or documents are linked to this record.
Ran from Apr 2019 to primary completion in Sep 2021, 29 months.
Of 3,697 non-industry interventional studies with no phase under Obesity, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 43. This study's 29 months is above that.
Counting every sponsor, half of 3,861 studies reached it within 22 months; a quarter within 9 and three quarters within 42.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
The Hospital of Vestfold